Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to MarketBeat Daily Ratings so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
Send Confirmation Email

Cardlytics (CDLX) News Today

→ Elon to Transform U.S. Economy? (From Porter & Company) (Ad)
Free CDLX Stock Alerts
$8.79
-0.48 (-5.18%)
(As of 05/17/2024 08:53 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability
May 15, 2024 | insidertrades.com
Insider Buying: Cardlytics, Inc. (NASDAQ:CDLX) Major Shareholder Acquires 3,746 Shares of Stock
May 14, 2024 | americanbankingnews.com
Cardlytics, Inc. (NASDAQ:CDLX) Major Shareholder Purchases $33,676.54 in Stock
May 14, 2024 | americanbankingnews.com
Cardlytics, Inc. (NASDAQ:CDLX) Major Shareholder Purchases $1,964,250.00 in Stock
May 13, 2024 | americanbankingnews.com
Craig Hallum Trims Cardlytics (NASDAQ:CDLX) Target Price to $12.00
May 13, 2024 | americanbankingnews.com
Cardlytics (NASDAQ:CDLX) PT Lowered to $12.00 at Needham & Company LLC
May 10, 2024 | insidermonkey.com
5 Best Marketing Stocks to Buy
May 10, 2024 | finance.yahoo.com
Cardlytics Inc (CDLX) Reports Q1 2024 Earnings: A Detailed Analysis
May 10, 2024 | americanbankingnews.com
Cardlytics Sees Unusually Large Options Volume (NASDAQ:CDLX)
May 9, 2024 | fool.com
Why Cardlytics Stock Collapsed on Thursday
May 9, 2024 | marketbeat.com
Craig Hallum Cuts Cardlytics (NASDAQ:CDLX) Price Target to $12.00
Craig Hallum cut their price target on Cardlytics from $18.00 to $12.00 and set a "buy" rating on the stock in a report on Thursday.
May 9, 2024 | marketwatch.com
Cardlytics Shares Plummet After Swing to 1Q Loss, Revenue Miss
May 9, 2024 | finance.yahoo.com
Cardlytics, Inc. (NASDAQ:CDLX) Q1 2024 Earnings Call Transcript
May 9, 2024 | marketbeat.com
Trading was temporarily halted for "CDLX" at 09:05 AM with a stated reason of "LULD pause."
May 9, 2024 | investorplace.com
Why Is Cardlytics (CDLX) Stock Down 29% Today?
May 9, 2024 | finance.yahoo.com
Cardlytics Inc (CDLX) Q1 2024 Earnings Call Transcript Highlights: A Mixed Bag of Growth and ...
May 8, 2024 | sfgate.com
Cardlytics: Q1 Earnings Snapshot
May 8, 2024 | msn.com
Cardlytics reports mixed Q1 results; initiates Q2 outlook
May 8, 2024 | globenewswire.com
Cardlytics Announces First Quarter 2024 Financial Results
May 2, 2024 | globenewswire.com
Cardlytics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 1, 2024 | marketbeat.com
Cardlytics (CDLX) Scheduled to Post Earnings on Wednesday
Cardlytics (NASDAQ:CDLX) will be releasing earnings after the market closes on Wednesday, May 8, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=588904)
April 30, 2024 | finance.yahoo.com
CDLX Jul 2024 9.000 put (CDLX240719P00009000)
April 25, 2024 | investing.com
Cardlytics executive sells over $3.5k in stock
April 25, 2024 | insidertrades.com
Insider Selling: Cardlytics, Inc. (NASDAQ:CDLX) COO Sells 23,416 Shares of Stock
April 24, 2024 | marketbeat.com
Cardlytics, Inc. (NASDAQ:CDLX) COO Sells $278,884.56 in Stock
Cardlytics, Inc. (NASDAQ:CDLX - Get Free Report) COO Amit Gupta sold 23,416 shares of the company's stock in a transaction dated Wednesday, April 24th. The stock was sold at an average price of $11.91, for a total transaction of $278,884.56. Following the completion of the transaction, the chief operating officer now owns 122,676 shares in the company, valued at $1,461,071.16. The sale was disclosed in a filing with the SEC, which is available through this link.
April 24, 2024 | finance.yahoo.com
Cardlytics Announces Timing of Its First Quarter 2024 Earnings Release
April 19, 2024 | finance.yahoo.com
Cardlytics, Inc. (CDLX)
April 17, 2024 | seekingalpha.com
The Power Of Cardlytics' Data Partnerships Including Bank of America
April 12, 2024 | marketbeat.com
Vanguard Group Inc. Boosts Stake in Cardlytics, Inc. (NASDAQ:CDLX)
Vanguard Group Inc. boosted its position in shares of Cardlytics, Inc. (NASDAQ:CDLX - Free Report) by 13.0% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,011,705 shares of the company's stock after buying a
April 11, 2024 | marketbeat.com
Cardlytics (NASDAQ:CDLX) Trading 4.7% Higher
Cardlytics (NASDAQ:CDLX) Stock Price Up 4.7%
April 11, 2024 | marketbeat.com
Baillie Gifford & Co. Cuts Stake in Cardlytics, Inc. (NASDAQ:CDLX)
Baillie Gifford & Co. cut its position in Cardlytics, Inc. (NASDAQ:CDLX - Free Report) by 9.9% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 946,058 shares of the company's stock after selling 103,390 shares during the period. Baillie Gifford & Co. owned a
April 9, 2024 | globenewswire.com
Liane Hornsey Appointed to Cardlytics Board of Directors
April 9, 2024 | markets.businessinsider.com
Buy Rating Reaffirmed for Cardlytics Amid Growth Prospects and Strategic American Express Partnership
April 9, 2024 | markets.businessinsider.com
The Analyst Verdict: Cardlytics In The Eyes Of 5 Experts
April 9, 2024 | marketbeat.com
Cardlytics (NASDAQ:CDLX) Price Target Increased to $17.00 by Analysts at Needham & Company LLC
Needham & Company LLC boosted their price target on Cardlytics from $15.00 to $17.00 and gave the company a "buy" rating in a research report on Tuesday.
April 8, 2024 | finance.yahoo.com
Is There An Opportunity With Cardlytics, Inc.'s (NASDAQ:CDLX) 31% Undervaluation?
April 7, 2024 | marketbeat.com
Assenagon Asset Management S.A. Buys 82,152 Shares of Cardlytics, Inc. (NASDAQ:CDLX)
Assenagon Asset Management S.A. boosted its stake in Cardlytics, Inc. (NASDAQ:CDLX - Free Report) by 540.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 97,351 shares of the company's stock after acquiring an
April 4, 2024 | markets.businessinsider.com
Craig-Hallum Reaffirms Their Buy Rating on Cardlytics (CDLX)
April 4, 2024 | marketbeat.com
Cardlytics (NASDAQ:CDLX) Shares Up 5.3%
Cardlytics (NASDAQ:CDLX) Trading Up 5.3%
April 3, 2024 | marketbeat.com
Cardlytics (NASDAQ:CDLX) Shares Down 3.7% on Insider Selling
Cardlytics (NASDAQ:CDLX) Stock Price Down 3.7% on Insider Selling
April 3, 2024 | insidertrades.com
Cardlytics, Inc. (NASDAQ:CDLX) Insider Nicholas Hollmeyer Lynton Sells 12,460 Shares
April 3, 2024 | finance.yahoo.com
Cardlytics Inc (CDLX) Chief Legal & Privacy Officer Nicholas Lynton Sells 12,460 Shares
April 3, 2024 | finance.yahoo.com
Cardlytics Inc (CDLX) CEO Karim Temsamani Sells 32,718 Shares
April 2, 2024 | marketbeat.com
Nicholas Hollmeyer Lynton Sells 12,460 Shares of Cardlytics, Inc. (NASDAQ:CDLX) Stock
Cardlytics, Inc. (NASDAQ:CDLX - Get Free Report) insider Nicholas Hollmeyer Lynton sold 12,460 shares of the business's stock in a transaction dated Tuesday, April 2nd. The stock was sold at an average price of $13.69, for a total transaction of $170,577.40. Following the completion of the transaction, the insider now directly owns 71,355 shares of the company's stock, valued at $976,849.95. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
April 2, 2024 | fool.com
Why Cardlytics Stock Skyrocketed 75% Last Month
April 1, 2024 | msn.com
Cliff Sosin Portfolio: Inside the Mind of an Investing Genius
March 28, 2024 | marketbeat.com
Cardlytics (NASDAQ:CDLX) Shares Down 4.4%
Cardlytics (NASDAQ:CDLX) Shares Down 4.4%
March 27, 2024 | marketbeat.com
Cardlytics (NASDAQ:CDLX) Sees Unusually-High Trading Volume
Cardlytics (NASDAQ:CDLX) Sees Strong Trading Volume
March 27, 2024 | msn.com
Why Cardlytics (CDLX) Stock Is Down 30%
March 27, 2024 | msn.com
Is Cardlytics Stock a Buy After Insider's $13.9M Investment?
March 26, 2024 | globenewswire.com
Cardlytics Prices $150.0 Million Convertible Senior Notes Offering
Get Cardlytics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CDLX and its competitors with MarketBeat's FREE daily newsletter.

Crypto Pioneer Says: “The last crypto bull market has begun.” (Ad)

Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.

Click here if you’d like to learn more about these five cryptos…

CDLX Media Mentions By Week

CDLX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CDLX
News Sentiment
▼
0.80

0.47
▲
Average
Business Services
News Sentiment

CDLX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CDLX Articles
This Week
▼
7

3
▲
CDLX Articles
Average Week

Get Cardlytics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CDLX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:CDLX) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
Urgent Nvidia Warning
Altimetry
The Overlooked Retirement Asset You Probably Don’t Own
Crypto 101 Media
Shocking: One AI startup's revenue could surge 4,735%
Manward Press
"The Biggest Drug Ever" Is Coming
Behind the Markets
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders
CEO of Biggest AI Chipmaker Just Dropped a Bombshell…
Banyan Hill Publishing
Elon’s New Device is About to Shock the World
InvestorPlace
Most important medical advance in 100 years
The Oxford Club